A detailed history of Alpha Centric Advisors LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 67,500 shares of RPRX stock, worth $1.76 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
67,500
Previous 60,000 12.5%
Holding current value
$1.76 Million
Previous $1.58 Million 20.67%
% of portfolio
1.61%
Previous 1.31%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$25.63 - $29.27 $192,225 - $219,525
7,500 Added 12.5%
67,500 $1.91 Million
Q1 2024

Apr 24, 2024

BUY
$27.46 - $31.33 $549,200 - $626,600
20,000 Added 50.0%
60,000 $1.82 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $1.05 Million - $1.17 Million
40,000 New
40,000 $1.12 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.4B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.